Pioneering New Treatment Strategies for Melanoma
11 January 2023
Over the last few decades, the melanoma research community has made tremendous progress detecting several genes that when altered cause melanoma, including those involved in melanoma’s growth and development. In addition, scientists have uncovered key enzymes that regulate the expression of critical tumor-associated genes — called epigenetic factors.
Ask the Experts: Melanoma Research Update
8 December 2022
From promising clinical trial results to new treatment approaches and an evolving standard of care, 2022 has proven to be an exciting year of advances in melanoma research. As MRA continues to look ahead, we also want to take a moment to reflect on these advances and what they mean for melanoma patients, families, and the community at large.
More Time, More Research, More Hope: Double your Impact!
29 November 2022 In Allies & Partnerships, Events, News
To share their gratitude for all those who are making a difference in melanoma research, our founders — Debra & Leon Black — are matching all gifts* to MRA up to $1 MILLION this holiday season. Donate Today!
Artificial Intelligence & Melanoma Detection: Closing the Gaps
15 November 2022
The earlier a cancer is detected, the better the patient’s prognosis. However, detecting melanoma isn't always clear cut. We currently identify melanoma based on subjective visual criteria and accuracy varies greatly from practitioner to practitioner and clinic to clinic. Artificial intelligence has the potential to improve this, but isn't quite ready for primetime.
From Melanoma Patient to Caregiver
By Renee Orcione, MRA Digital Engagement & Communications Manager | 11 November 2022
By the time she was 26-years old, Leah Adams had spent countless hours tanning. Growing up in Ohio where the winters were long, she felt a pressure to stay tan far beyond the summer months, so she turned to tanning beds.
The Changing Melanoma Landscape
7 November 2022
Before 2011, the melanoma treatment arena was in a sustained drought during which patients were only offered a few treatments, and few with advanced stages of the cancer were still alive a year after starting treatment.
Facing Melanoma Together: Kate O'Neil
31 October 2022
Prior to the creation of modern melanoma therapies, Kate O'Neil's sister Noreen was diagnosed, treated, and ultimately passed away from the disease. To honor her sister's legacy, Kate has become a champion of melanoma research.
FDA Approves Opzulera for At-Home Therapy for Skin Repigmentation: What this Means for Melanoma Patients with Vitiligo
By Isabel Ryan, MRA Intern | 24 October 2022 In News, Science
On July 18th, the U.S. Food & Drug Administration (FDA) approved the first topically-applied treatment for skin repigmentation for patients with vitiligo after strong results from two Phase 3 trials. Vitiligo, a chronic skin disease, affects 3 in 100 people who have melanoma, categorized as melanoma-associated vitiligo. The approval invites patients with vitiligo, including those with melanoma, to talk with their providers on how Opzelura can serve their skin needs.
Music vs. Melanoma: 13-Year-Old Raises $6K for Research
By Renee Orcione, MRA Digital Engagement & Communications Manager | 7 October 2022
Cassidy Battin, an 8th grader from Carlsbad, California, and her family are no strangers to melanoma. Her great aunt sadly died of uveal melanoma, a rare subtype that forms in the eye, when Cassidy was younger. Her grandfather also had melanoma, along with several other loved ones in the family.
Fish & Melanoma: What’s the Connection?
By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 4 October 2022 In News
A study led by researchers at Brown University surprisingly found that people who ate the most fish were the most likely to develop melanoma. Before you change your diet, read more about the study, its findings, and limitations.